John Boris

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst John Boris works at ROTH and is focused on the Healthcare sector with 85 price targets and ratings documented since 2013 spanning on 8 stocks. Previously, John Boris worked at TRUIST. Analyst's average stock valuation to be materialised ratio is 74.17% with an average time for price targets to be met of 719.13 days.

Most recent stock forecast was given on AMRX, Amneal Pharmaceuticals, Inc at 11-Jul-2019.

John Boris best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS, INC).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS, INC) at 12/18/2018. The price target of $13 was fulfilled within 27 days with a profit of $2.91 (18.29%) receiving and performance score of 6.77.

Average potential price target upside

of $45.79 (59.32%) on ABBV (ABBVIE INC).
of $28.43 (42.35%) on LLY (ELI LILLY AND COMPANY).
of $15.11 (32.25%) on MRK (MERCK & CO., INC).

Currently, out of the existing stock ratings of John Boris - 3577 which are a Buy (65.86%), 1658 which are a Hold (30.53%), 196 which are a Sell (3.61%)